A considerable range of interindividual sensitivity to a DNA alkylating agent. (A) The percentage of control growth of the cell lines at 72 h after treatment with MNNG (0.5 μg/mL) using a growth inhibition assay. The division between high and low sensitivity among the cell lines is demarcated at 53% with a red dotted line. (B) The percentage of survival of cell lines 6 and 7 was determined 10 d after treatment with MNNG and compared with three control cell lines (TK6, TK6 + MGMT, and MT1) using a killing curve assay. (C) Fold increase in caspase-3 activity was determined 72 h post-treatment with MNNG across the cell line panel.

Modulation of C21ORF56, MYH, and Myh influences MNNG sensitivity. (A) TK6 cells expressing a control shRNA (WT) or shRNA specifically targeting the C21ORF56 transcript (v1), or the MYH transcript (v1), were assessed for the percentage of survival after exposure to MNNG. The inset shows the percentage of transcript remaining C21ORF56 and MYH in knockdown cells. (B) Percentage of survival of Myh^−/− or wild-type MEFs determined after treatment with MNNG.

Identification of ASA genes that predict interindividual differences in alkylation sensitivity. (A) Three ASA gene sets were identified from a training population comprising the four most sensitive and the four least sensitive cell lines including (1) 48 genes derived from basal gene expression (the BASA set), (2) 39 genes derived from treatment-to-basal expression ratio (the TRASA set), and (3) 121 genes derived from treatment-induced expression (the TASA set). Expression patterns for the gene sets are shown for both the training and the test populations of cell lines. Expression values are mean centered with high relative expression indicated in red and low relative expression indicated in blue. (B) The sensitivity of the test population of cell lines to MNNG was predicted using three algorithms: SVM, NC, and PLSR. The two-class prediction algorithms were used with each of the three ASA gene sets as well as the MGMT transcript alone. Correct prediction is indicated with a white box; incorrect prediction, with a black box. (C) MGMT expression level is plotted versus the percentage of control growth of the cell lines treated with MNNG. Red circles indicate cell lines of the training population, and blue circles indicate cell lines of the test population. (D) O⁶-MeG DNA methyltransferase activity was determined in protein extracts derived from cell lines 4, 7, 20, 12, 22, and 8. Methyltransferase activity is plotted versus the baseline expression level of MGMT in each cell line. (E) Methyltransferase activity is plotted versus the percentage of control growth for the same cell lines as in (D).

Basal expression networks associated with interindividual differences in sensitivity to MNNG. (A) A heat map of the 240 basally differentially expressed genes identified between two classes of the training population, those with highest and lowest MNNG sensitivity. Expression values are mean centered with high relative expression indicated in red and low relative expression indicated in blue. (B) Of the 240 genes from A, 148 were present in the Ingenuity database. These 148 proteins were analyzed for significant enrichment of molecular interactions. A significant (P < 10⁻¹⁰) interactome of 328 total proteins containing 125 of the 148 proteins was identified. (C) The most significant subnetwork (P < 10⁻³⁰) of ASA proteins. (D) The second most significant subnetwork (P < 10⁻²⁶) of ASA proteins. Proteins in red are encoded by transcripts with high basal expression in cells with low MNNG sensitivity, and proteins in green are encoded by transcripts with high basal expression in cells with high MNNG sensitivity; proteins in white are associated with these ASA proteins. Tumorigenesis-associated proteins (TAPs) are indicated with an asterisk and TAP proteins containing Oct-1-binding sites are indicated with two asterisks.